Masayoshi Tasaki

2.5k total citations
80 papers, 1.4k citations indexed

About

Masayoshi Tasaki is a scholar working on Molecular Biology, Physiology and Nephrology. According to data from OpenAlex, Masayoshi Tasaki has authored 80 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 21 papers in Physiology and 16 papers in Nephrology. Recurrent topics in Masayoshi Tasaki's work include Amyloidosis: Diagnosis, Treatment, Outcomes (61 papers), Alzheimer's disease research and treatments (16 papers) and Parathyroid Disorders and Treatments (15 papers). Masayoshi Tasaki is often cited by papers focused on Amyloidosis: Diagnosis, Treatment, Outcomes (61 papers), Alzheimer's disease research and treatments (16 papers) and Parathyroid Disorders and Treatments (15 papers). Masayoshi Tasaki collaborates with scholars based in Japan, United States and Italy. Masayoshi Tasaki's co-authors include Yukio Ando, Mitsuharu Ueda, Konen Obayashi, Yohei Misumi, Hirofumi Jono, Taro Yamashita, Satoru Shinriki, Toshinori Oshima, Giampaolo Merlini and Francesca Lavatelli and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Masayoshi Tasaki

77 papers receiving 1.4k citations

Peers

Countries citing papers authored by Masayoshi Tasaki

Since Specialization

Citations

This map shows the geographic impact of Masayoshi Tasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Tasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Tasaki more than expected).

Fields of papers citing papers by Masayoshi Tasaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayoshi Tasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Tasaki. The network helps show where Masayoshi Tasaki may publish in the future.

Co-authorship network of co-authors of Masayoshi Tasaki

This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Tasaki. A scholar is included among the top collaborators of Masayoshi Tasaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Tasaki. Masayoshi Tasaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Characterization of heterozygous ATTR Tyr114Cys amyloidosis-specific induced pluripotent stem cells 2024 ·Heliyon ·(unknown), Kaori Isono, Yuki Ohya, Nobuaki Shiraki, Masayoshi Tasaki, Yukihiro Inomata, Mitsuharu Ueda, Takumi Era, Shoen Kume, Yukio Ando, Hirofumi Jono	2
2	TIF1β activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia 2024 ·Leukemia ·(unknown), Sho Kubota, (unknown), Takako Yokomizo‐Nakano, (unknown), Jie Bai, (unknown), Masayoshi Tasaki, Yukio Ando, Kimi Araki, Goro Sashida	2
3	Epidemiological study of the subtype frequency of systemic amyloidosis listed in the Annual of the Pathological Autopsy Cases in Japan 2023 ·Pathology International ·(unknown), Masayoshi Tasaki, Mitsuharu Ueda, Yukio Ando, Hironobu Naiki	3
4	Correlation between a commercial electrophysiological test of sudomotor function and intraepidermal nerve fiber density in hereditary transthyretin amyloidosis 2023 ·Muscle & Nerve ·Teruaki Masuda, Yohei Misumi, Toshiya Nomura, (unknown), Masayoshi Tasaki, Konen Obayashi, Yukio Ando, Mitsuharu Ueda	0
5	α-Enolase reduces cerebrovascular Aβ deposits by protecting Aβ amyloid formation 2022 ·Cellular and Molecular Life Sciences ·Yasuteru Inoue, Masayoshi Tasaki, Teruaki Masuda, Yohei Misumi, Toshiya Nomura, Yukio Ando, Mitsuharu Ueda	2
6	Step-by-Step Typing for the Accurate Diagnosis of Concurrent Light Chain and Transthyretin Cardiac Amyloidosis 2022 ·ESC Heart Failure ·Hidenori Moriyama, Hiroki Kitakata, Jin Endo, Hidehiko Ikura, Motoaki Sano, Masayoshi Tasaki, Shunta Sakai, Mitsuharu Ueda, Keiichi Fukuda	2
7	Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis 2020 ·Journal of Biological Chemistry ·Francesca Lavatelli, Giulia Mazzini, Stéfano Ricagno, Federica Iavarone, Paola Rognoni, Paolo Milani, Mario Nuvolone, Paolo Swuec, (unknown), Masayoshi Tasaki, Antonio Chaves-Sanjuán, Andrea Urbani, Giampaolo Merlini, Giovanni Palladini	40
8	Plasma Growth Differentiation Factor 15: A Novel Tool to Detect Early Changes of Hereditary Transthyretin Amyloidosis 2020 ·ESC Heart Failure ·(unknown), Yohei Misumi, Teruaki Masuda, (unknown), Masayoshi Tasaki, Hiroaki Matsushita, Mitsuharu Ueda, Yasuteru Inoue, Toshiya Nomura, Makoto Nakajima, Taro Yamashita, Satoru Shinriki, Hirotaka Matsui, Kenichi Tsujita, Yukio Ando	6
9	Novel dot-blot assay for detection of vascular Notch3 aggregates in patients with CADASIL 2020 ·Journal of the Neurological Sciences ·Yihong Ma, Mitsuharu Ueda, Satoru Shinriki, (unknown), (unknown), (unknown), Masayoshi Tasaki, Toshiya Nomura, Yasuteru Inoue, Teruaki Masuda, Yohei Misumi, Taro Yamashita, Hirotaka Matsui, Yukio Ando	5
10	ATR-FTIR Spectroscopy Supported by Multivariate Analysis for the Characterization of Adipose Tissue Aspirates from Patients Affected by Systemic Amyloidosis 2019 ·Analytical Chemistry ·Diletta Ami, Paolo Mereghetti, Andrea Foli, Masayoshi Tasaki, Paolo Milani, Mario Nuvolone, Giovanni Palladini, Giampaolo Merlini, Francesca Lavatelli, Antonino Natalello	25
11	A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH 2019 ·Journal of Biological Chemistry ·Mitsuharu Ueda, (unknown), Mineyuki Mizuguchi, Barbara Kluve‐Beckerman, (unknown), (unknown), Yohei Misumi, Masayoshi Tasaki, Akinori Kanai, (unknown), Teruaki Masuda, Yasuteru Inoue, Toshiya Nomura, Satoru Shinriki, Tsuyoshi Shuto, Hirofumi Kai, Taro Yamashita, Hirotaka Matsui, Merrill D. Benson, Yukio Ando	16
12	Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient 2019 ·Nature Communications ·Paolo Swuec, Francesca Lavatelli, Masayoshi Tasaki, Cristina Paissoni, Paola Rognoni, Martina Maritan, Francesca Brambilla, Paolo Milani, Pierluigi Mauri, Carlo Camilloni, Giovanni Palladini, Giampaolo Merlini, Stéfano Ricagno, Martino Bolognesi	119
13	New simple and quick method to analyze serum variant transthyretins: direct MALDI method for the screening of hereditary transthyretin amyloidosis 2019 ·Orphanet Journal of Rare Diseases ·Toshiya Nomura, Mitsuharu Ueda, Masayoshi Tasaki, Yohei Misumi, Teruaki Masuda, Yasuteru Inoue, (unknown), (unknown), Takahiro Okazaki, (unknown), (unknown), Makoto Nakamura, Konen Obayashi, Satoru Shinriki, Hirotaka Matsui, Taro Yamashita, Yukio Ando	5
14	Amyloid Fibril Formation of Immunoglobulin Light Chain Peptide from IHC-Negative AL Amyloidosis and Its Inhibition By Doxycycline and Epigallocatechin 2017 ·Blood ·Hiroyuki Hata, (unknown), Mitsuharu Ueda, Nao Nishimura, Shinya Endo, Yutaka Okuno, Taro Yamashita, Konen Obayashi, Masayoshi Tasaki, (unknown), (unknown), (unknown), Yukio Ando	1
15	Serum amyloid P component: A novel potential player in vessel degeneration in CADASIL 2017 ·Journal of the Neurological Sciences ·(unknown), Mitsuharu Ueda, Masayoshi Tasaki, Yasuteru Inoue, Yihong Ma, Teruaki Masuda, (unknown), Sayaka Matsumoto, Takayuki Kosaka, Takayuki Kawano, Takaaki Ito, Yukio Ando	10
16	Knee osteoarthritis associated with different kinds of amyloid deposits and the impact of aging on type of amyloid 2015 ·Amyloid ·(unknown), Mitsuharu Ueda, Takanao Sueyoshi, Eiichi Nakamura, Masayoshi Tasaki, (unknown), (unknown), (unknown), (unknown), Yohei Misumi, Taro Yamashita, (unknown), Per Westermark, Hiroshi Mizuta, Yukio Ando	22
17	Concomitant accumulation of α-synuclein and TDP-43 in a patient with corticobasal degeneration 2014 ·Journal of Neurology ·Satoshi Yamashita, Naomi Sakashita, Taro Yamashita, Nozomu Tawara, Masayoshi Tasaki, (unknown), Yoshihiro Komohara, Y. Fujiwara, (unknown), Takenobu Nakagawa, Teruyuki Hirano, Yasushi Maeda, Masato Hasegawa, Motohiro Takeya, Yukio Ando	13
18	Impact of antibodies against amyloidogenic transthyretin (ATTR) on phenotypes of patients with familial amyloidotic polyneuropathy (FAP) ATTR Valine30Methionine 2013 ·Clinica Chimica Acta ·Konen Obayashi, Masayoshi Tasaki, Hirofumi Jono, Mitsuharu Ueda, Satoru Shinriki, Yohei Misumi, Taro Yamashita, Toshinori Oshima, Teruya Nakamura, Shinji Ikemizu, Intissar Anan, Ole B. Suhr, Yukio Ando	6
19	Transthyretin-derived amyloid deposition in the heart of an elderly Japanese population 2011 ·Amyloid ·(unknown), Yasuhiro Horibata, Mitsuharu Ueda, Masayoshi Tasaki, Yohei Misumi, Jianying Guo, M. Shono, Hirofumi Jono, Konen Obayashi, Hisao Ogawa, Yukio Ando	1
20	Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human disease 2011 ·Laboratory Investigation ·Mitsuharu Ueda, Naohide Ageyama, Shinichiro Nakamura, (unknown), James Chambers, Yohei Misumi, Mineyuki Mizuguchi, Satoru Shinriki, (unknown), Masayoshi Tasaki, Hirofumi Jono, Konen Obayashi, Erika Sasaki, Yumi Une, Yukio Ando	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact